Skip to main content
Erschienen in: Drugs & Therapy Perspectives 2/2024

10.03.2024 | Practical Issues and Updates

Metformin reduces the complications of gestational diabetes mellitus but its long-term effects on offspring require further study

verfasst von: Simon Fung

Erschienen in: Drugs & Therapy Perspectives | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Gestational diabetes mellitus (GDM) can lead to serious complication during pregnancy both for the pregnant person and the developing offspring. Intensive lifestyle intervention, including diet and exercise, is effective in managing this disorder, although pharmacotherapy (typically insulin) will still be required in approximately a quarter of these patients. Recent studies have shown that metformin can also be efficacious in reducing complications associated with GDM, however, longer-term safety data in offspring are still required.
Literatur
1.
Zurück zum Zitat Schafer-Graf UM, Gembruch U, Kainer F, et al. Gestational Diabetes Mellitus (GDM)—diagnosis, treatment and follow-up. Guideline of the DDG and DGGG. Geburtshilfe Frauenheilkd. 2018;78(12):1219–31.CrossRefPubMedPubMedCentral Schafer-Graf UM, Gembruch U, Kainer F, et al. Gestational Diabetes Mellitus (GDM)—diagnosis, treatment and follow-up. Guideline of the DDG and DGGG. Geburtshilfe Frauenheilkd. 2018;78(12):1219–31.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 190 summary: gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):406–8.CrossRef American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 190 summary: gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):406–8.CrossRef
3.
Zurück zum Zitat ElSayed NA, Aleppo G, Aroda VR, et al. 15. Management of diabetes in pregnancy: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S254–66.CrossRefPubMed ElSayed NA, Aleppo G, Aroda VR, et al. 15. Management of diabetes in pregnancy: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S254–66.CrossRefPubMed
5.
Zurück zum Zitat Simmons D. Paradigm shifts in the management of diabetes in pregnancy: the importance of type 2 diabetes and early hyperglycemia in pregnancy (the 2020 Norbert Freinkel award lecture). Diabetes Care. 2021;44(5):1075–81.CrossRefPubMed Simmons D. Paradigm shifts in the management of diabetes in pregnancy: the importance of type 2 diabetes and early hyperglycemia in pregnancy (the 2020 Norbert Freinkel award lecture). Diabetes Care. 2021;44(5):1075–81.CrossRefPubMed
6.
Zurück zum Zitat Langley-Evans SC, Pearce J, Ellis S. Overweight, obesity and excessive weight gain in pregnancy as risk factors for adverse pregnancy outcomes: a narrative review. J Hum Nutr Diet. 2022;35(2):250–64.CrossRefPubMedPubMedCentral Langley-Evans SC, Pearce J, Ellis S. Overweight, obesity and excessive weight gain in pregnancy as risk factors for adverse pregnancy outcomes: a narrative review. J Hum Nutr Diet. 2022;35(2):250–64.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Pascual-Morena C, Cavero-Redondo I, Alvarez-Bueno C, et al. Exercise versus metformin to improve pregnancy outcomes among overweight pregnant women: a systematic review and network meta-analysis. J Clin Med. 2021;10(16):3490.CrossRefPubMedPubMedCentral Pascual-Morena C, Cavero-Redondo I, Alvarez-Bueno C, et al. Exercise versus metformin to improve pregnancy outcomes among overweight pregnant women: a systematic review and network meta-analysis. J Clin Med. 2021;10(16):3490.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Ouyang H, Al-Mureish A, Wu N. Research progress of metformin in gestational diabetes mellitus: a narrative review. Ann Palliat Med. 2021;10(3):3423–37.CrossRefPubMed Ouyang H, Al-Mureish A, Wu N. Research progress of metformin in gestational diabetes mellitus: a narrative review. Ann Palliat Med. 2021;10(3):3423–37.CrossRefPubMed
10.
Zurück zum Zitat Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(Suppl 3):S173-211.CrossRefPubMed Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(Suppl 3):S173-211.CrossRefPubMed
13.
Zurück zum Zitat Sandall J, Tribe RM, Avery L, et al. Short-term and long-term effects of caesarean section on the health of women and children. Lancet. 2018;392(10155):1349–57.CrossRefPubMed Sandall J, Tribe RM, Avery L, et al. Short-term and long-term effects of caesarean section on the health of women and children. Lancet. 2018;392(10155):1349–57.CrossRefPubMed
14.
Zurück zum Zitat Bogdanet D, Egan A, Reddin C, et al. ATLANTIC DIP: despite insulin therapy in women with IADPSG diagnosed GDM, desired pregnancy outcomes are still not achieved. What are we missing? Diabetes Res Clin Pract. 2018;136:116–23.CrossRefPubMed Bogdanet D, Egan A, Reddin C, et al. ATLANTIC DIP: despite insulin therapy in women with IADPSG diagnosed GDM, desired pregnancy outcomes are still not achieved. What are we missing? Diabetes Res Clin Pract. 2018;136:116–23.CrossRefPubMed
15.
Zurück zum Zitat Vanda R, Bazrafkan M, Rouhani M, et al. Comparing pregnancy, childbirth, and neonatal outcomes in women with idiopathic polyhydramnios: a prospective cohort study. BMC Pregnancy Childbirth. 2022;22(1):399.CrossRefPubMedPubMedCentral Vanda R, Bazrafkan M, Rouhani M, et al. Comparing pregnancy, childbirth, and neonatal outcomes in women with idiopathic polyhydramnios: a prospective cohort study. BMC Pregnancy Childbirth. 2022;22(1):399.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Kwak SH, Choi SH, Jung HS, et al. Clinical and genetic risk factors for type 2 diabetes at early or late post partum after gestational diabetes mellitus. J Clin Endocrinol Metab. 2013;98(4):e744–52.CrossRefPubMed Kwak SH, Choi SH, Jung HS, et al. Clinical and genetic risk factors for type 2 diabetes at early or late post partum after gestational diabetes mellitus. J Clin Endocrinol Metab. 2013;98(4):e744–52.CrossRefPubMed
17.
Zurück zum Zitat Tobias DK, Hu FB, Forman JP, et al. Increased risk of hypertension after gestational diabetes mellitus: findings from a large prospective cohort study. Diabetes Care. 2011;34(7):1582–4.CrossRefPubMedPubMedCentral Tobias DK, Hu FB, Forman JP, et al. Increased risk of hypertension after gestational diabetes mellitus: findings from a large prospective cohort study. Diabetes Care. 2011;34(7):1582–4.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Chodick G, Tenne Y, Barer Y, et al. Gestational diabetes and long-term risk for dyslipidemia: a population-based historical cohort study. BMJ Open Diabetes Res Care. 2020;8(1): e000870.CrossRefPubMedPubMedCentral Chodick G, Tenne Y, Barer Y, et al. Gestational diabetes and long-term risk for dyslipidemia: a population-based historical cohort study. BMJ Open Diabetes Res Care. 2020;8(1): e000870.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Voormolen DN, de Wit L, van Rijn BB, et al. Neonatal hypoglycemia following diet-controlled and insulin-treated gestational diabetes mellitus. Diabetes Care. 2018;41(7):1385–90.CrossRefPubMed Voormolen DN, de Wit L, van Rijn BB, et al. Neonatal hypoglycemia following diet-controlled and insulin-treated gestational diabetes mellitus. Diabetes Care. 2018;41(7):1385–90.CrossRefPubMed
20.
Zurück zum Zitat Kawakita T, Bowers K, Hazrati S, et al. Increased neonatal respiratory morbidity associated with gestational and pregestational diabetes: a retrospective study. Am J Perinatol. 2017;34(11):1160–8.CrossRefPubMedPubMedCentral Kawakita T, Bowers K, Hazrati S, et al. Increased neonatal respiratory morbidity associated with gestational and pregestational diabetes: a retrospective study. Am J Perinatol. 2017;34(11):1160–8.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat He J, Song J, Zou Z, et al. Association between neonatal hyperbilirubinemia and hypoglycemia in Chinese women with diabetes in pregnancy and influence factors. Sci Rep. 2022;12(1):16975.CrossRefPubMedPubMedCentral He J, Song J, Zou Z, et al. Association between neonatal hyperbilirubinemia and hypoglycemia in Chinese women with diabetes in pregnancy and influence factors. Sci Rep. 2022;12(1):16975.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Lowe WL, Scholtens DM, Lowe LP, et al. Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA. 2018;320(10):1005–16.CrossRefPubMedPubMedCentral Lowe WL, Scholtens DM, Lowe LP, et al. Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA. 2018;320(10):1005–16.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Clausen TD, Mathiesen ER, Hansen T, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care. 2008;31(2):340–6.CrossRefPubMed Clausen TD, Mathiesen ER, Hansen T, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care. 2008;31(2):340–6.CrossRefPubMed
24.
Zurück zum Zitat Tam WH, Ma RCW, Ozaki R, et al. In utero exposure to maternal hyperglycemia increases childhood cardiometabolic risk in offspring. Diabetes Care. 2017;40(5):679–86.CrossRefPubMedPubMedCentral Tam WH, Ma RCW, Ozaki R, et al. In utero exposure to maternal hyperglycemia increases childhood cardiometabolic risk in offspring. Diabetes Care. 2017;40(5):679–86.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Wright CS, Rifas-Shiman SL, Rich-Edwards JW, et al. Intrauterine exposure to gestational diabetes, child adiposity, and blood pressure. Am J Hypertens. 2009;22(2):215–20.CrossRefPubMed Wright CS, Rifas-Shiman SL, Rich-Edwards JW, et al. Intrauterine exposure to gestational diabetes, child adiposity, and blood pressure. Am J Hypertens. 2009;22(2):215–20.CrossRefPubMed
26.
Zurück zum Zitat Xiang AH, Wang X, Martinez M, et al. Association of maternal diabetes with autism in offspring. JAMA. 2015;313(14):1425–34.CrossRefPubMed Xiang AH, Wang X, Martinez M, et al. Association of maternal diabetes with autism in offspring. JAMA. 2015;313(14):1425–34.CrossRefPubMed
27.
Zurück zum Zitat Zhao L, Li X, Liu G, et al. The association of maternal diabetes with attention deficit and hyperactivity disorder in offspring: a meta-analysis. Neuropsychiatr Dis Treat. 2019;15:675–84.CrossRefPubMedPubMedCentral Zhao L, Li X, Liu G, et al. The association of maternal diabetes with attention deficit and hyperactivity disorder in offspring: a meta-analysis. Neuropsychiatr Dis Treat. 2019;15:675–84.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Qiao LX, Wang J, Yan J-H, et al. Follow-up study of neurodevelopment in 2-year-old infants who had suffered from neonatal hypoglycemia. BMC Pediatr. 2019;19:133. Qiao LX, Wang J, Yan J-H, et al. Follow-up study of neurodevelopment in 2-year-old infants who had suffered from neonatal hypoglycemia. BMC Pediatr. 2019;19:133.
30.
Zurück zum Zitat Wiernsperger NF, Bailey CJ. The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs. 1999;58(Suppl. 1):31–9.CrossRefPubMed Wiernsperger NF, Bailey CJ. The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs. 1999;58(Suppl. 1):31–9.CrossRefPubMed
31.
Zurück zum Zitat Brown J, Martis R, Hughes B, et al. Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017;1(1):CD011967.PubMed Brown J, Martis R, Hughes B, et al. Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017;1(1):CD011967.PubMed
32.
33.
Zurück zum Zitat Simmons D, Immanuel J, Hague WM, et al. Treatment of gestational diabetes mellitus diagnosed early in pregnancy. N Engl J Med. 2023;388(23):2132–44.CrossRefPubMed Simmons D, Immanuel J, Hague WM, et al. Treatment of gestational diabetes mellitus diagnosed early in pregnancy. N Engl J Med. 2023;388(23):2132–44.CrossRefPubMed
34.
Zurück zum Zitat Kovo M, Kogman N, Ovadia O, et al. Carrier-mediated transport of metformin across the human placenta determined by using the ex vivo perfusion of the placental cotyledon model. Prenat Diagn. 2008;28(6):544–8.CrossRefPubMed Kovo M, Kogman N, Ovadia O, et al. Carrier-mediated transport of metformin across the human placenta determined by using the ex vivo perfusion of the placental cotyledon model. Prenat Diagn. 2008;28(6):544–8.CrossRefPubMed
35.
Zurück zum Zitat Gardiner SJ, Kirkpatrick CMJ, Begg EJ, et al. Transfer of metformin into human milk. Clin Pharmacol Ther. 2003;73(1):71–7.CrossRefPubMed Gardiner SJ, Kirkpatrick CMJ, Begg EJ, et al. Transfer of metformin into human milk. Clin Pharmacol Ther. 2003;73(1):71–7.CrossRefPubMed
36.
Zurück zum Zitat Ratner RE, Christophi CA, Metzger BE, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 2008;93(12):4774–9.CrossRefPubMedPubMedCentral Ratner RE, Christophi CA, Metzger BE, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 2008;93(12):4774–9.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Aroda VR, Christophi CA, Edelstein SL, et al. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the diabetes prevention program outcomes study 10-year follow-up. J Clin Endocrinol Metab. 2015;100(4):1646–53.CrossRefPubMedPubMedCentral Aroda VR, Christophi CA, Edelstein SL, et al. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the diabetes prevention program outcomes study 10-year follow-up. J Clin Endocrinol Metab. 2015;100(4):1646–53.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Rowan JA, Rush EC, Plank LD, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age. BMJ Open Diabetes Res Care. 2018;6(6): e000456.CrossRefPubMedPubMedCentral Rowan JA, Rush EC, Plank LD, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age. BMJ Open Diabetes Res Care. 2018;6(6): e000456.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Given JE, Loane M, Garne E, et al. Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study. BMJ. 2018;361: k2477.CrossRefPubMedPubMedCentral Given JE, Loane M, Garne E, et al. Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study. BMJ. 2018;361: k2477.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19):2003–15.CrossRefPubMed Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19):2003–15.CrossRefPubMed
41.
Zurück zum Zitat Salomäki H, Vähätalo LH, Laurila K, et al. Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood. PLoS ONE. 2013;8(2): e56594.CrossRefPubMedPubMedCentral Salomäki H, Vähätalo LH, Laurila K, et al. Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood. PLoS ONE. 2013;8(2): e56594.CrossRefPubMedPubMedCentral
Metadaten
Titel
Metformin reduces the complications of gestational diabetes mellitus but its long-term effects on offspring require further study
verfasst von
Simon Fung
Publikationsdatum
10.03.2024
Verlag
Springer International Publishing
Erschienen in
Drugs & Therapy Perspectives / Ausgabe 2/2024
Print ISSN: 1172-0360
Elektronische ISSN: 1179-1977
DOI
https://doi.org/10.1007/s40267-024-01047-y

Weitere Artikel der Ausgabe 2/2024

Drugs & Therapy Perspectives 2/2024 Zur Ausgabe